• Print
  •  

ViroSeq® HIV-1 Genotyping System

CE Marked
View Ordering Information
Product Name Quantity Order # Additional Information

ViroSeq HIV-1 Genotyping System v2.0 Kit, CE

  • Sample Preparation Module
  • RT-PCR Module
  • Sequencing Module
  • 8E5 Control Module
 48 Tests/Kit 4J94-93

ViroSeq HIV-1 Genotyping System v2.0 Kit, (FDA IVD)

  • Sample Preparation Module
  • RT-PCR Module
  • Sequencing Module
  • 8E5 Control Module
 48 Tests/Kit 4J94-91

Sequencing Consumables Kit

  • MicroAmp® Optical 96-Well Reaction Plates with Lids - 2 packs (5/Pack)
  • MicroAmp® Reaction Tubes with Caps - 2 bags (55/bag)
 96 Tests/Kit 4J94-92
PCR Cleanup Kit 96 Tests/Kit 4J94-73

Intended Use 
The ViroSeq HIV-1 Genotyping System is intended for use in detecting HIV genomic mutations that confer resistance to specific types of antiretroviral drugs, as an aid in monitoring and treating HIV infection. Specifically, the ViroSeq HIV-1 Genotyping System can be used to:

  • Detect HIV-1 Subtype B viral resistance in plasma samples collected in EDTA with a viral load ranging from 2000 to 750,000 copies/mL
  • Genotype the entire HIV-1 protease gene from codons 1-99 and two-thirds of the reverse transcriptase (RT) gene from codons 1-335

Indication for Use
The indications for use encompass the following populations:

  • HIV-1 infected individuals at drug therapy failure (with increased viral load) before therapy switch
  • HIV-1 infected individuals at initial presentation, before initial drug therapy

Completely Integrated

  • High throughput processing with automated sequencing
  • Integrated system including sample preparation, RT-PCR, cycle sequencing module, and positive controls
  • Autoloading of samples provides walkaway processing

Completely Targeted

  • Software converts continuous sequenced data for entire protease and 1 to 335 codons in reverse transcriptase to patient report
  • Comprehensive drug resistance interpretation algorithm.
  • Software provides interpretive resistance report to aid in treatment decisions

Completely In - Depth

  • In depth understanding leads to targeted treatment decisions
  • Integrated system from sample prep to final report
  • Unattended hands-free capillary electrophoresis
  • Powerful analysis software provides comprehensive drug resistance reports to assist with treatment decisions

Complete Genomic Coverage

  • Seven sequencing reactions with forward and reverse orientations achieve full codon coverage
  • Redundant sequencing primers provide overlappping genomic coverage

Most Complete Genomic Coverage
Seven sequencing reactions with forward and reverse orientations achieve full codon coverage.  Redundant sequencing primers provide multiple genomic coverage.

Viroseq_hiv1_genotyping_system_pic


Time-Saving ViroSeq HIV-1 Genotyping System Workflow*Viro_Seq_Time-saving_viroseq_workflow_pic


*For processing 12 samples on the ABI Prism® 3100/3130 Genetic Analyzers

CE Marked